Trusting artificial intelligence in cybersecurity is a double-edged sword

被引:74
|
作者
Taddeo, Mariarosaria [1 ,2 ]
McCutcheon, Tom [3 ]
Floridi, Luciano [1 ,2 ]
机构
[1] Univ Oxford, Oxford Internet Inst, Oxford, England
[2] British Lib, Alan Turing Inst, London, England
[3] Def Sci & Technol Labs, Salisbury, Wilts, England
基金
英国工程与自然科学研究理事会;
关键词
D O I
10.1038/s42256-019-0109-1
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Applications of artificial intelligence (AI) for cybersecurity tasks are attracting greater attention from the private and the public sectors. Estimates indicate that the market for AI in cybersecurity will grow from US$1 billion in 2016 to a US$34.8 billion net worth by 2025. The latest national cybersecurity and defence strategies of several governments explicitly mention AI capabilities. At the same time, initiatives to define new standards and certification procedures to elicit users' trust in AI are emerging on a global scale. However, trust in AI (both machine learning and neural networks) to deliver cybersecurity tasks is a double-edged sword: it can improve substantially cybersecurity practices, but can also facilitate new forms of attacks to the AI applications themselves, which may pose severe security threats. We argue that trust in AI for cybersecurity is unwarranted and that, to reduce security risks, some form of control to ensure the deployment of 'reliable AI' for cybersecurity is necessary. To this end, we offer three recommendations focusing on the design, development and deployment of AI for cybersecurity. Current national cybersecurity and defence strategies of several governments mention explicitly the use of AI. However, it will be important to develop standards and certification procedures, which involves continuous monitoring and assessment of threats. The focus should be on the reliability of AI-based systems, rather than on eliciting users' trust in AI.
引用
收藏
页码:557 / 560
页数:4
相关论文
共 50 条
  • [41] Natalizumab: A Double-Edged Sword?
    DeAngelis, Lisa M.
    ANNALS OF NEUROLOGY, 2009, 66 (03) : 262 - 263
  • [42] The double-edged sword of evolution
    Kruzel-Davila, Etty
    Skorecki, Karl
    ELIFE, 2017, 6
  • [43] MAVS is a double-edged sword
    Huang, Christina
    Arbiser, Jack L.
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2023, 33 : 869 - 870
  • [44] Hypothermia: A Double-Edged Sword
    Todaro, Maria Chiara
    Oreto, Lilia
    Gupta, Anjan
    Bajwa, Tanvir
    Khandheria, Bijoy K.
    CARDIOLOGY, 2012, 122 (02) : 126 - 128
  • [45] The Blockade as a Double-Edged Sword
    Regalado, Roberto
    MONTHLY REVIEW-AN INDEPENDENT SOCIALIST MAGAZINE, 2022, 73 (08) : 11 - 22
  • [46] Herbicides - a double-edged sword?
    Kudsk, P
    Streibig, JC
    12TH EWRS (EUROPEAN WEED RESEARCH SOCIETY) SYMPOSIUM 2002, WAGENINGEN, PROCEEDINGS, 2002, : 94 - 95
  • [47] The double-edged sword of adenosine
    Plo, Isabelle
    Antony-Debre, Ileana
    HAEMATOLOGICA, 2024, 109 (01) : 13 - 15
  • [48] DOCUMENTATION - A DOUBLE-EDGED SWORD
    BALL, AE
    PERSONNEL, 1989, 66 (04) : 96 - 100
  • [49] THE DOUBLE-EDGED SWORD OF SCIENCE
    COKER, WR
    ASHRAE JOURNAL, 1989, 31 (12) : 5 - 5
  • [50] The double-edged sword of bivalency
    Bulut-Karslioglu, Aydan
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2024, 25 (01) : 6 - 6